Mandy O. Grootaert (United Kingdom)

University of Cambridge Department of Medicine
Dr. Mandy O.J. Grootaert is a postdoctoral research fellow in Prof. Martin Bennett’s group at the University of Cambridge, UK. After completing her Masters in Pharmaceutical Sciences in 2011 at the University of Antwerp, Belgium, she began her PhD at the lab of Physio Pharmacology, where she investigated the role of cell death and autophagy in atherosclerosis. Her interest in cardiovascular aging prompted her to join the lab of Prof. Martin Bennett in 2016. Her current research focuses on identifying the molecular mechanisms that regulate vascular smooth muscle cell senescence and the effect on atherosclerosis.

Author Of 3 Presentations

Senescence in atherosclerosis (ID 1355)

Session Type
Plenary Session
Session Time
17:30 - 19:00
Date
Tue, 01.06.2021
Room
Hall B (Live Q&A)
Lecture Time
17:45 - 18:00

Live Q&A (ID 1434)

Session Type
Plenary Session
Session Time
17:30 - 19:00
Date
Tue, 01.06.2021
Room
Hall B (Live Q&A)
Lecture Time
18:30 - 19:00

O068 - Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury (ID 194)

Session Type
Vascular Biology
Session Time
10:30 - 12:00
Date
Wed, 02.06.2021
Room
Live Streamed
Lecture Time
11:27 - 11:35

Abstract

Background and Aims

Background and Aims: Vascular smooth muscle cells (VSMCs) accumulate in injury-induced neointimal lesions and atherosclerotic plaques in an oligoclonal fashion, yet plaque VSMCs show reduced proliferation and cell senescence. DNA damage leads to VSMC senescence and inflammation and VSMC senescence promotes atherosclerosis; however, the exact mechanism by which VSMC senescence promotes lesion formation is not known. Here, we investigated telomere damage-induced VSMC senescence, the contribution of senescence-induced inflammation and the mechanisms involved, the consequences of VSMC senescence in vivo after injury, and whether it promotes clonality.

Methods

Methods: Stress-induced premature senescence (SIPS) was induced by doxorubicin (24h treatment+21d recovery). Lentiviruses were used to stably overexpress a dysfunctional TRF2 mutant protein (TRF2T188A) in hVSMCs. SM22αTRF2T188A mice were generated that express human TRF2T188A in VSMCs only, and crossed with Myh11-CreERT2 Rosa26-Confetti multicolour reporter mice to examine cell senescence and clonality in vivo.

Results

Results: Both SIPS and TRF2188A-induced VSMC senescence were characterised by persistent telomere damage, and associated with formation of micronuclei, activation of cGAS-STING cytoplasmic DNA sensing, and induction of multiple pro-inflammatory cytokines. Silencing of cGAS in TRF2T188A hVSMCs partially inhibited NFκB-dependent cytokine expression. In vivo, VSMC-specific TRF2T188A expression in a multicolour VSMC-tracking model demonstrated no change in VSMC clonal patches after injury, but increased neointima formation, outward remodelling, and immune/inflammatory cell infiltration or retention.

Conclusions

Conclusion: Persistent telomere damage promotes VSMC senescence and inflammation and exacerbates neointima formation after injury. Our data suggest that persistent telomere damage-induced VSMC senescence plays a major role in driving inflammation through immune cell recruitment in vascular disease.

Hide

Presenter of 3 Presentations

Senescence in atherosclerosis (ID 1355)

Session Type
Plenary Session
Session Time
17:30 - 19:00
Date
Tue, 01.06.2021
Room
Hall B (Live Q&A)
Lecture Time
17:45 - 18:00

Live Q&A (ID 1434)

Session Type
Plenary Session
Session Time
17:30 - 19:00
Date
Tue, 01.06.2021
Room
Hall B (Live Q&A)
Lecture Time
18:30 - 19:00

O068 - Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury (ID 194)

Session Type
Vascular Biology
Session Time
10:30 - 12:00
Date
Wed, 02.06.2021
Room
Live Streamed
Lecture Time
11:27 - 11:35

Abstract

Background and Aims

Background and Aims: Vascular smooth muscle cells (VSMCs) accumulate in injury-induced neointimal lesions and atherosclerotic plaques in an oligoclonal fashion, yet plaque VSMCs show reduced proliferation and cell senescence. DNA damage leads to VSMC senescence and inflammation and VSMC senescence promotes atherosclerosis; however, the exact mechanism by which VSMC senescence promotes lesion formation is not known. Here, we investigated telomere damage-induced VSMC senescence, the contribution of senescence-induced inflammation and the mechanisms involved, the consequences of VSMC senescence in vivo after injury, and whether it promotes clonality.

Methods

Methods: Stress-induced premature senescence (SIPS) was induced by doxorubicin (24h treatment+21d recovery). Lentiviruses were used to stably overexpress a dysfunctional TRF2 mutant protein (TRF2T188A) in hVSMCs. SM22αTRF2T188A mice were generated that express human TRF2T188A in VSMCs only, and crossed with Myh11-CreERT2 Rosa26-Confetti multicolour reporter mice to examine cell senescence and clonality in vivo.

Results

Results: Both SIPS and TRF2188A-induced VSMC senescence were characterised by persistent telomere damage, and associated with formation of micronuclei, activation of cGAS-STING cytoplasmic DNA sensing, and induction of multiple pro-inflammatory cytokines. Silencing of cGAS in TRF2T188A hVSMCs partially inhibited NFκB-dependent cytokine expression. In vivo, VSMC-specific TRF2T188A expression in a multicolour VSMC-tracking model demonstrated no change in VSMC clonal patches after injury, but increased neointima formation, outward remodelling, and immune/inflammatory cell infiltration or retention.

Conclusions

Conclusion: Persistent telomere damage promotes VSMC senescence and inflammation and exacerbates neointima formation after injury. Our data suggest that persistent telomere damage-induced VSMC senescence plays a major role in driving inflammation through immune cell recruitment in vascular disease.

Hide